Lexeo Therapeutics Growth Metrics (2022-2023) | LXEO

Growth Metrics Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Growth Ratios
Capital Expenditures Growth (1y) 68.00%
Capital Expenditures (QoQ) -52.00%250.00%-54.76%121.05%
Cash & Equivalents Growth (1y) -62.35%
Cash & Equivalents (QoQ) -17.86%
Cash from Investing Activities Growth (1y) 31.78%
Cash from Investing Activities (QoQ) -37.74%
Cash from Operations Growth (1y) 15.91%
Cash from Operations (QoQ) -10.51%28.20%-5.74%-0.23%
EBITDA Margin Growth (1y) 4.23M0.18M
EBITDA Margin (QoQ) 3.14M1.04M-1.22M1.26M-0.90M
EBIT Growth (1y) -15.96%1.47%
EBIT Margin Growth (1y) 4.23M0.18M
EBIT Margin (QoQ) 3.14M1.04M-1.22M1.26M-0.90M
EBIT (QoQ) 13.07%-26.93%27.55%-45.07%26.14%
EBT Growth (1y) -17.90%2.68%
EBT Margin Growth (1y) 4.19M0.14M
EBT Margin (QoQ) 3.02M1.03M-1.20M1.33M-1.03M
EBT (QoQ) 14.53%-27.99%27.96%-49.60%29.45%
Enterprise Value Growth (1y) 62.35%562.38%
Enterprise Value (QoQ) 17.86%1,108.73%
EPS (Basic) Growth (1y) -19.08%323.93%
EPS (Basic) (QoQ) 14.64%-30.70%28.32%-48.92%260.52%
EPS (Weighted Average and Diluted) Growth (1y) -19.08%323.93%
EPS (Weighted Average and Diluted) (QoQ) 14.64%-30.70%28.32%-48.92%260.52%
FCF Margin Growth (1y) -0.28M
FCF Margin (QoQ) 0.59M-1.18M0.19M0.12M
Free Cash Flow Growth (1y) 15.78%
Free Cash Flow (QoQ) -10.42%28.02%-5.55%-0.39%
Interest Coverage Ratio Growth (1y) 35.33%-6.42%
Interest Coverage Ratio (QoQ) 53.32%-37.09%31.65%-47.86%23.18%
Net Cash Flow Growth (1y) 611.58%
Net Cash Flow (QoQ) -9.86%28.07%24.06%952.50%
Net Income Growth (1y) -17.90%2.68%
Net Income (QoQ) 14.53%-27.99%27.96%-49.60%29.45%
Net Income towards Common Stockholders Growth (1y) -17.90%2.68%
Net Income towards Common Stockholders (QoQ) 14.53%-27.99%27.96%-49.60%29.45%
Net Margin Growth (1y) 4.19M0.14M
Net Margin (QoQ) 3.02M1.03M-1.20M1.33M-1.03M
Operating Income Growth (1y) -15.96%1.47%
Operating Income (QoQ) 13.07%-26.93%27.55%-45.07%26.14%
Operating Margin Growth (1y) 4.23M0.18M
Operating Margin (QoQ) 3.14M1.04M-1.22M1.26M-0.90M
Profit After Tax Growth (1y) -17.90%2.79%
Profit After Tax (QoQ) 14.39%-27.79%27.96%-49.60%29.42%
Return on Sales (QoQ) 0.05M433.00
Revenue Growth (1y) -109.79%7.41%
Revenue (QoQ) -110.17%7.41%-6.00%1.89%3.85%
Share-based Compensation Growth (1y) 102.78%54.32%
Share-based Compensation (QoQ) 20.88%-23.80%144.08%-9.80%-8.01%
Shareholder's Equity Growth (1y) -64.49%
Shareholder's Equity (QoQ) -14.12%